REG - Oxford Biomedica PLC - Block listing return

Oxford BioMedicaAnnouncement

03/01/2023 17:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230103:nRSC5695La&default-theme=true

RNS Number : 5695L  Oxford Biomedica PLC  03 January 2023

 Name of applicant:                                                                OXFORD BIOMEDICA PLC
 Name of scheme:                                                                   2015 Employee Share Option Scheme
 Period of return:                        From:                                    1 July 2022   To:           31 December 2022
 Balance of unallotted securities under scheme(s) from previous return:            336,239
 Plus:  The amount by which the block scheme(s) has been increased since the       NIL
 date of the last return (if any increase has been applied for):
 Less:  Number of securities issued/allotted under scheme(s) during period         4,665
 (see LR3.5.7G):
 Equals:  Balance under scheme(s) not yet issued/allotted at end of period:        331,574

 

 

 Name of applicant:                                                                OXFORD BIOMEDICA PLC
 Name of scheme:                                                                   2015 Long Term Incentive Plan
 Period of return:                        From:                                    1 July 2022  To:         31 December 2022
 Balance of unallotted securities under scheme(s) from previous return:            519,668
 Plus:  The amount by which the block scheme(s) has been increased since the       NIL
 date of the last return (if any increase has been applied for):
 Less:  Number of securities issued/allotted under scheme(s) during period         180,349
 (see LR3.5.7G):
 Equals:  Balance under scheme(s) not yet issued/allotted at end of period:        339,319

 

 

 

 Name of applicant:                                                                OXFORD BIOMEDICA PLC
 Name of scheme:                                                                   2015 Deferred Bonus Plan
 Period of return:                        From:                                    1 July 2022  To:        31 December 2022
 Balance of unallotted securities under scheme(s) from previous return:            206,835
 Plus:  The amount by which the block scheme(s) has been increased since the       NIL
 date of the last return (if any increase has been applied for):
 Less:  Number of securities issued/allotted under scheme(s) during period         4,390
 (see LR3.5.7G):
 Equals:  Balance under scheme(s) not yet issued/allotted at end of period:        202,445

 

 

 

 Name of applicant:                                                                OXFORD BIOMEDICA PLC
 Name of scheme:                                                                   Sharesave Scheme
 Period of return:                        From:                                    1 July 2022  To:      31 December 2022
 Balance of unallotted securities under scheme(s) from previous return:            331,484
 Plus:  The amount by which the block scheme(s) has been increased since the       NIL
 date of the last return (if any increase has been applied for):
 Less:  Number of securities issued/allotted under scheme(s) during period         NIL
 (see LR3.5.7G):
 Equals:  Balance under scheme(s) not yet issued/allotted at end of period:        331,484

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BLRBJMRTMTBMBPJ